Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 30, 2008
Identification of hydroxywarfarin binding site in human UDP glucuronosyltransferase 1a10: phenylalanine90 is crucial for the glucuronidation of 6- and 7-hydroxywarfarin but not 8-hydroxywarfarin
Grover P Miller, Cheryl F Lichti, Agnieszka K Zielinska, et al.
International Journal of Nanomedicine
|
July 2, 2011
Ethylenediamine functionalized-single-walled nanotube (f-SWNT)-assisted in vitro delivery of the oncogene suppressor p53 gene to breast cancer MCF-7 cells
Alokita Karmakar, Stacie M Bratton, Enkeleda Dervishi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 13, 2011
Conjugation of synthetic cannabinoids JWH-018 and JWH-073, metabolites by human UDP-glucuronosyltransferases
Krishna C Chimalakonda, Stacie M Bratton, Vi-Huyen Le, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 12, 2014
A potential role for human UDP-glucuronosyltransferase 1A4 promoter single nucleotide polymorphisms in the pharmacogenomics of tamoxifen and its derivatives
Aleksandra K Greer, Centdrika R Dates, Athena Starlard-Davenport, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 1, 2007
The first aspartic acid of the DQxD motif for human UDP-glucuronosyltransferase 1A10 interacts with UDP-glucuronic acid during catalysis
Yan Xiong, Anne-Sisko Patana, Michael J Miley, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 3, 2009
Characterization of human hepatic and extrahepatic UDP-glucuronosyltransferase enzymes involved in the metabolism of classic cannabinoids
Anna Mazur, Cheryl F Lichti, Paul L Prather, et al.
Cancer Biology & Therapy
|
May 22, 2015
Human UDP-Glucuronosyltransferases: Effects of altered expression in breast and pancreatic cancer cell lines
Centdrika R Dates, Tariq Fahmi, Sebastian J Pyrek, et al.
Journal of Applied Toxicology : JAT
|
September 16, 2014
Single-walled carbon nanotube and graphene nanodelivery of gambogic acid increases its cytotoxicity in breast and pancreatic cancer cells
Lamya M Saeed, Meena Mahmood, Sebastian J Pyrek, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
October 6, 2011
Natural prenylated resveratrol analogs arachidin-1 and -3 demonstrate improved glucuronidation profiles and have affinity for cannabinoid receptors
Lisa K Brents, Fabricio Medina-Bolivar, Kathryn A Seely, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 21, 2012
Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands
Krishna C Chimalakonda, Kathryn A Seely, Stacie M Bratton, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 30, 2008
Identification of hydroxywarfarin binding site in human UDP glucuronosyltransferase 1a10: phenylalanine90 is crucial for the glucuronidation of 6- and 7-hydroxywarfarin but not 8-hydroxywarfarin
Grover P Miller, Cheryl F Lichti, Agnieszka K Zielinska, et al.
International Journal of Nanomedicine
|
July 2, 2011
Ethylenediamine functionalized-single-walled nanotube (f-SWNT)-assisted in vitro delivery of the oncogene suppressor p53 gene to breast cancer MCF-7 cells
Alokita Karmakar, Stacie M Bratton, Enkeleda Dervishi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 13, 2011
Conjugation of synthetic cannabinoids JWH-018 and JWH-073, metabolites by human UDP-glucuronosyltransferases
Krishna C Chimalakonda, Stacie M Bratton, Vi-Huyen Le, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 12, 2014
A potential role for human UDP-glucuronosyltransferase 1A4 promoter single nucleotide polymorphisms in the pharmacogenomics of tamoxifen and its derivatives
Aleksandra K Greer, Centdrika R Dates, Athena Starlard-Davenport, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 1, 2007
The first aspartic acid of the DQxD motif for human UDP-glucuronosyltransferase 1A10 interacts with UDP-glucuronic acid during catalysis
Yan Xiong, Anne-Sisko Patana, Michael J Miley, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 3, 2009
Characterization of human hepatic and extrahepatic UDP-glucuronosyltransferase enzymes involved in the metabolism of classic cannabinoids
Anna Mazur, Cheryl F Lichti, Paul L Prather, et al.
Cancer Biology & Therapy
|
May 22, 2015
Human UDP-Glucuronosyltransferases: Effects of altered expression in breast and pancreatic cancer cell lines
Centdrika R Dates, Tariq Fahmi, Sebastian J Pyrek, et al.
Journal of Applied Toxicology : JAT
|
September 16, 2014
Single-walled carbon nanotube and graphene nanodelivery of gambogic acid increases its cytotoxicity in breast and pancreatic cancer cells
Lamya M Saeed, Meena Mahmood, Sebastian J Pyrek, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
October 6, 2011
Natural prenylated resveratrol analogs arachidin-1 and -3 demonstrate improved glucuronidation profiles and have affinity for cannabinoid receptors
Lisa K Brents, Fabricio Medina-Bolivar, Kathryn A Seely, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 21, 2012
Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands
Krishna C Chimalakonda, Kathryn A Seely, Stacie M Bratton, et al.
Page
of 3